JezK

Edit File: 1642007353.M903204P206652.mocha3025.mochahost.com,S=114657,W=117041:2,S

From: <dr.safar@jack.ngo>
To: <takal@jack.ngo>
Cc: <ahmad@jack.ngo>,
	<nooromari@jack.ngo>,
	<haseeb.shirzada@jack.ngo>,
	<finance.manager@jack.ngo>,
	<finance.advisor@jack.ngo>
References: <007701d719a6$5153c930$f3fb5b90$@jack.ngo> <!&!AAAAAAAAAAAuAAAAAAAAAK+whLNHJnZLnYDb4fLeB80BAMO2jhD3dRHOtM0AqgC7tuYAAAAAAA4AABAAAADn+wNFvFnYSoPoAS9WN/N/AQAAAAA=@jack.ngo> <005e01d74040$648d85c0$2da89140$@jack.ngo> <!&!AAAAAAAAAAAuAAAAAAAAAK+whLNHJnZLnYDb4fLeB80BAMO2jhD3dRHOtM0AqgC7tuYAAAAAAA4AABAAAAC/LKTvAmgVSJSNjnP06dt3AQAAAAA=@jack.ngo> 
In-Reply-To: 
Subject: FW: Rejected and not received medicine
Date: Sun, 26 Sep 2021 11:46:06 +0430
Message-ID: <001c01d7b2a6$62daf130$2890d390$@jack.ngo>
MIME-Version: 1.0
Content-Type: multipart/related;
	boundary="----=_NextPart_000_10848_01D807FC.D78C2A70"
Thread-Index: AQIwKTvpzDoM5QD4M3IF3aqBB1HSrgHFTt8gAVPZ+SsBiyelvwJrPK8/
Content-Language: en-us

This is a multipart message in MIME format.

------=_NextPart_000_10848_01D807FC.D78C2A70
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_10849_01D807FC.D78C2A70"

------=_NextPart_001_10849_01D807FC.D78C2A70
Content-Type: text/plain;
	charset="utf-8"
Content-Transfer-Encoding: 8bit

Dear Takal Sahib

As per pressure from Taliban at the time of implementing Trauma project in 
field, we had a request of medicine change from Main office, it was accepted 
and the cost was 23530 Afghanis.

The mission was to change 450 Falgyl Syrup to 450 Flagyl Serum and 2250 
Salin 500ml to 2250 Saline 1000ml.

We received the total amount from supplier (450 Falgyl Serum and 2250 Salin 
1000ml),

but we did not deliver the total amount we promised.

We delivered 295 Falgyl Syrup and 2230 Saline 500ml serums. We could not 
deliver 155 Flagyl Syrup and 30 Saline 500ml

You can go through my previous email for the reasons.

According to market prices, each Falgyl syrup is cost 33 Afghanis and each 
Serum Salin 500ml is cost 22 Afghanis.

155x33= 5115

30x22= 660

In total 5775 Afghanis. This amount medicines were available in our FATPs, 
our Pharmacy assistant was not able to receive them, when we asked them 
after several days, he responded that the Taliban forcefully did not deliver 
the medicines.

Beside from invoice, we have to pay 23530+5775= 29305 Afghanis to the 
supplier. The amount 5775 should be deducted from Pharmacy assistant’s 
salary (after clarification with him) and 23530 from any other financial 
line (the last quarter lines were not used in Kunduz province)

Thank you & Best Regards

Dr-Mohammad Hashim “Safar” MD/GP/Social Service Provider

Emergency projects Technical Manager

Just for Afghan Capacity and Knowledge       بلند بردن سطح دانش و توانمندی 
افغانها (جک)

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93790807013 – +93777 469 663

Official Email: <mailto:Dr.Safar@jack.ngo> Dr.Safar@jack.ngo

Personal Email: <mailto:Dr.Safar@yahoo.com> Dr.Safar@yahoo.com

Skype ID: <mailto:Dr.Safar001@outlook.com> Dr.Safar001@outlook.com

Website:www.jack.ngo

From: dr.safar@jack.ngo [mailto:dr.safar@jack.ngo]
Sent: Wednesday, August 4, 2021 11:01 AM
To: 'ahmad@jack.ngo' <ahmad@jack.ngo>
Cc: 'hadi@jack.ngo' <hadi@jack.ngo>; 'logistic.manager@jack.ngo' 
<logistic.manager@jack.ngo>; 'fatima.qasimi@jack.ngo' 
<fatima.qasimi@jack.ngo>; 'finance.manager@jack.ngo' 
<finance.manager@jack.ngo>; 'takal@jack.ngo' <takal@jack.ngo>; 
'nooromari@jack.ngo' <nooromari@jack.ngo>
Subject: RE: Rejected and not received medicine

Dear Dr Ahmad

As per below emails and justifications, 155 Flagyl syrups and 30 Serum 
saline were not delivered to the supplier according to our exchange plan.

The exchange plan was to:

*        450 Flagyl Syrup should have been replaced with 450 Flagyl solution

*        2250 saline syrum of 500 Mile liter should have been replaced to 
2250 Saline syrum 1000 Mile Liter

295 flagyl syrup was delivered to the supplier, however, 155 was missed from 
Pharmacy assistant Mr Hakim Mangal as he said AOGs did not give them the 
exchanged Flagyl syrups.

From 2250 Syrums, total 2220 Syrums were delivered to supplier. 30 syrums 
remained from the exchange, the reasons was when the first supply happened 
to Jan Qataghan, the syrums of 1000 Mile Liter was sent, however, the 
exchange of it was not brought back to stock. Later AOGs only gave them 420 
syrums, 30 was used by FATP staff.

Total: 155 Flagyl syrup and 30 Saline 500 Mile liter was left and the reason 
was that Mr Hakim Mangal sent the medicine to FATPs and did not bring back 
it’s exchange, he said AOGs did not permit.

The real was that Mr Mangal reported the issue after 3 days. When the issue 
was followed up, FATP staff said we have submitted and there were no 
documents for hand over/take over. Not having a clear document for takeover 
of medicine was the fault of Pharmacy assistant.

Conclusion:  I would like to kindly request from top management team that 
declare their decision on the above mentioned issue. As it was raised by 
myself even months ago and there is no clear decision taken until now.

Thanks in advance

Thank you & Best Regards

Dr-Mohammad Hashim “Safar” MD/GP/Social Service Provider

Emergency projects focal point / COVID-19 Vaccination technical focal point

Just for Afghan Capacity and Knowledge       بلند بردن سطح دانش و توانمندی 
افغانها (جک)

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93790807013 – +93777 469 663

Official Email: <mailto:Dr.Safar@jack.ngo> Dr.Safar@jack.ngo

Personal Email: <mailto:Dr.Safar@yahoo.com> Dr.Safar@yahoo.com

Website:www.jack.ngo

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> 
[mailto:pharmacy@jack.ngo]
Sent: Monday, June 21, 2021 8:30 AM
To: fatima.qasimi@jack.ngo <mailto:fatima.qasimi@jack.ngo>
Cc: hadi@jack.ngo <mailto:hadi@jack.ngo> ; dr.safar@jack.ngo 
<mailto:dr.safar@jack.ngo> ; ahmad@jack.ngo <mailto:ahmad@jack.ngo>
Subject: FW: Rejected and not received medicine

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> 
[mailto:pharmacy@jack.ngo]
Sent: Tuesday, May 4, 2021 1:28 PM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> >; 
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo 
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' <hamdard@jack.ngo 
<mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; 
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; 'ghani@jack.ngo' 
<ghani@jack.ngo <mailto:ghani@jack.ngo> >; 'takal@jack.ngo' <takal@jack.ngo 
<mailto:takal@jack.ngo> >; 'mirzaee@jack.ngo' <mirzaee@jack.ngo 
<mailto:mirzaee@jack.ngo> >; 'ahf-finance@jack.ngo' <ahf-finance@jack.ngo 
<mailto:ahf-finance@jack.ngo> >; 'musawy@jack.ngo' <musawy@jack.ngo 
<mailto:musawy@jack.ngo> >; 'nooromari@jack.ngo' <nooromari@jack.ngo 
<mailto:nooromari@jack.ngo> >
Subject: RE: Rejected and not received medicine

Dear Dr. Sahib Safar,

Thanks from your email and justifications, the attached informal GRN shows 
that the medicines delivered to supplier without pharmacy committee and 
incomplete, but KDZ-AHF team promised to deliver complete rejected amount to 
supplier, the financial cost of this exchange was and will be:

1.      Complete exchange cost: 23,530 AFN

2.      Incomplete exchange cost: 41,590 AFN

As now the medicine delivered to supplier incompletely, I would like to know 
how we should pay 41,590 AFN to supplier, looking forward to hear from you 
soon.

Dear En. Sahib Hadi,

Kindly refer to below emails and let us know your comments.

Regards

Jamal

From: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> 
[mailto:dr.safar@jack.ngo]
Sent: Monday, May 3, 2021 9:49 PM
To: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> ; 
pharmacy.assistant@jack.ngo <mailto:pharmacy.assistant@jack.ngo> ; 
hamdard@jack.ngo <mailto:hamdard@jack.ngo>
Cc: ahmad@jack.ngo <mailto:ahmad@jack.ngo> ; hadi@jack.ngo 
<mailto:hadi@jack.ngo> ; ghani@jack.ngo <mailto:ghani@jack.ngo> ; 
takal@jack.ngo <mailto:takal@jack.ngo> ; mirzaee@jack.ngo 
<mailto:mirzaee@jack.ngo> ; ahf-finance@jack.ngo 
<mailto:ahf-finance@jack.ngo> ; musawy@jack.ngo <mailto:musawy@jack.ngo> ; 
nooromari@jack.ngo <mailto:nooromari@jack.ngo>
Subject: RE: Rejected and not received medicine

Dear Dr Jamal

As per investigations, I found out there are two problems.

1.      Only 295 flagyl syrups were submitted to Supplier, in this case, 
Haji Naim Jan clininc flagyl syrup were not received although Pharmacy 
assistant delivered Metrogyls, however he says the AOG responsible did not 
give me flagyl syrups

2.      When we delivered the sample medicine to Jan Qataghan of Khanabad 
district for AOG check up, the Salin 500 Ml syrums were sent as well, 
however after rejection, they were not collected back, due to AOG said 
rejected medicine should be replaced in FATP. When we wanted to deliver the 
1000 Ml syrums of Salin, the pharmacy assistant did not collected salin 500 
ml back. Then the ban started from march 12 – 2021 1st May 2021. Now when he 
called to the AOGs that we want our 450 Salin 500 mL syrums back, then AOG 
responsible replied that “not collecting back the serums were NGOs fault and 
now we will not give it back we have sealed those serums and we will use it 
for our purpose”.

The conclusion: Two times the medicine were sent, however they were not 
collected back by Pharmacy assistant.

The rest of the decision is up to Kabul Management team what they decide, 
the cleareance of each and every staff is up hold, the decision on this 
section is easy if the AOGs do not give us back serums and flagyl syrups.

Currently I am communicating through community access mobilizer, will share 
the result of what is the final words of AOGs by tomorrow CoB.

Dr-Mohammad Hashim “Safar” MD/GP/Social Service Provider

Project Manager-AHF Project

Just for Afghan Capacity and Knowledge       بلند بردن سطح دانش و توانمندی 
افغانها (جک)

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93792711163

Email: <mailto:Dr.Safar@jack.ngo> Dr.Safar@jack.ngo

Email: <mailto:Parvez.Safar@gmail.com> Parvez.Safar@gmail.com

Website:www.jack.ngo

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> 
[mailto:pharmacy@jack.ngo]
Sent: Monday, May 3, 2021 1:18 PM
To: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> ; 
pharmacy.assistant@jack.ngo <mailto:pharmacy.assistant@jack.ngo> ; 
hamdard@jack.ngo <mailto:hamdard@jack.ngo>
Cc: ahmad@jack.ngo <mailto:ahmad@jack.ngo> ; hadi@jack.ngo 
<mailto:hadi@jack.ngo> ; ghani@jack.ngo <mailto:ghani@jack.ngo> ; 
takal@jack.ngo <mailto:takal@jack.ngo> ; mirzaee@jack.ngo 
<mailto:mirzaee@jack.ngo> ; ahf-finance@jack.ngo 
<mailto:ahf-finance@jack.ngo> ; musawy@jack.ngo <mailto:musawy@jack.ngo> ; 
nooromari@jack.ngo <mailto:nooromari@jack.ngo>
Subject: RE: Rejected and not received medicine

Gentle Reminder!

Dear AHF Team need your response regarding the subject issue, also let us 
know the way you delivered medicine to supplier along with delivered amount, 
looking forward to hear from you soon.

Regards

Jamal

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> 
[mailto:pharmacy@jack.ngo]
Sent: Saturday, May 1, 2021 1:53 PM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> >; 
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo 
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' <hamdard@jack.ngo 
<mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; 
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; 'ghani@jack.ngo' 
<ghani@jack.ngo <mailto:ghani@jack.ngo> >; 'takal@jack.ngo' <takal@jack.ngo 
<mailto:takal@jack.ngo> >; 'mirzaee@jack.ngo' <mirzaee@jack.ngo 
<mailto:mirzaee@jack.ngo> >; 'ahf-finance@jack.ngo' <ahf-finance@jack.ngo 
<mailto:ahf-finance@jack.ngo> >; 'musawy@jack.ngo' <musawy@jack.ngo 
<mailto:musawy@jack.ngo> >
Subject: RE: Rejected and not received medicine

Dear Dr. Safar and Amrullah Khan,

I hope you have been well, based on your request and top management approval 
we have exchanged the rejected medicine to requested medicine which your all 
fully aware of that, now we have pay 23,530 AFN to supplier due to exchange 
rate, to let you know finance team will pay the main procurement cost to 
supplier only exchange cost rate will be paid by you as it was agreed, 
attached is the supplier bank details, if there be any question please 
contact to finance team.

Regards

Jamal

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> 
[mailto:pharmacy@jack.ngo]
Sent: Tuesday, March 30, 2021 10:26 AM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> >; 
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo 
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' <hamdard@jack.ngo 
<mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; 
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; 'ghani@jack.ngo' 
<ghani@jack.ngo <mailto:ghani@jack.ngo> >; 'takal@jack.ngo' <takal@jack.ngo 
<mailto:takal@jack.ngo> >; 'mirzaee@jack.ngo' <mirzaee@jack.ngo 
<mailto:mirzaee@jack.ngo> >; 'ahf-finance@jack.ngo' <ahf-finance@jack.ngo 
<mailto:ahf-finance@jack.ngo> >; 'musawy@jack.ngo' <musawy@jack.ngo 
<mailto:musawy@jack.ngo> >
Subject: RE: Rejected and not received medicine

Dear Dr. Safar,

I am glad that you received the requested medicine for 4th Qtr of AHF 
project, which I didn’t get your confirmation nor GRN, please let me know 
about following comments:

1.      Vicryl 4/1 is not available at the market, which size will be the 
alternative (Vicryl size 4 or Vicryl size 1).

2.      Per your request and senior management approval we discussed and 
agreed with supplier to exchange the two rejected items (Serum-Saline 500ml 
& Syrup-Metro 200mg/30ml) to requested items (Serum-Saline 1000ml & 
Serum-Metro 500mg/30ml) beyond the main contract, now supplier is confused 
that when I will receive the exchanged items because he already send his 
representative three times to PO-M.Stock, in order to receive the exchange 
medicine but due to none reason the process get postponed, I would like to 
know if there is any problem and the exact time when your able to deliver 
the exchanged items to supplier.

Please let me know if there is anything that I can help you to accelerate 
the process and close the procurement process.

Best Regards,

JAMAL   Pharm.D

Procurement / Pharmacy Manger

Just for Afghan Capacity and Knowledge       بلند بردن سطح دانش و توانمندی 
افغانها (جک)

Address: 1st Street of Karta-e-Chahar, Kabul Afghanistan

Behind AWCC Main Office, House # 09

What’s app: +93 744 402 619

Email: pharm.dmrjamal@gmail.com <mailto:pharm.dmrjamal@gmail.com>

Website:www.jack.ngo

=======================================================================================================================================================================

This e-mail and any files transmitted with it may contain privileged or 
confidential information. It is solely for use by the individual for whom it 
is intended, even if addressed incorrectly. If you received this e-mail in 
error, please notify the sender; do not disclose copy, distribute, or take 
any action in reliance on the contents of this information; and delete it 
from your system. Any other use of this e-mail is prohibited. The views 
expressed herein are those of the author and do not necessarily reflect the 
views or policies of jack (Afghanistan). Electronic transmissions may be 
recorded and monitored.For Verification Please Read the Barcode Reader.

P Every 3000 sheets of paper costs us a tree. Please don't print this e-mail 
unless you really need to

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> 
[mailto:pharmacy@jack.ngo]
Sent: Tuesday, March 16, 2021 10:13 AM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> >; 
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo 
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' <hamdard@jack.ngo 
<mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; 
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; 'ghani@jack.ngo' 
<ghani@jack.ngo <mailto:ghani@jack.ngo> >; 'takal@jack.ngo' <takal@jack.ngo 
<mailto:takal@jack.ngo> >; 'mirzaee@jack.ngo' <mirzaee@jack.ngo 
<mailto:mirzaee@jack.ngo> >; 'ahf-finance@jack.ngo' <ahf-finance@jack.ngo 
<mailto:ahf-finance@jack.ngo> >; 'musawy@jack.ngo' <musawy@jack.ngo 
<mailto:musawy@jack.ngo> >
Subject: RE: Rejected and not received medicine

Dear Dr. Sahib Safar,

Thanks from your email, please review below comments:

1.      I received the draft of GRN and I found difference at 11 items, as I 
shared the list with supplier he send his representative to PO to solve the 
supply issue immediately, again I will follow this issue with supplier and 
will communicate you via phone.

2.      As we have agreed with supplier to exchange the two items which are 
quarantine right now at P-Stock and you received the replacement, please 
make them ready and pack in exact Qty and good package, please do the 
exchange process in presence of pharmacy committee.

3.      As I already talked with pharmacy team, so please inform them to 
prepare the GRN with all required info such as (expiry date, batch number, 
company & country, Qty, etc..).

4.      As you all aware that AHF-Projects will be audit by 3rd party team, 
so please inform the AHF pharmacy in charge to fully get ready for 
assessment.

Regards

Jamal

From: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> 
[mailto:dr.safar@jack.ngo]
Sent: Monday, March 15, 2021 6:50 PM
To: logitic.manager@jack.ngo <mailto:logitic.manager@jack.ngo>
Cc: ahmad@jack.ngo <mailto:ahmad@jack.ngo> ; hadi@jack.ngo 
<mailto:hadi@jack.ngo> ; ghani@jack.ngo <mailto:ghani@jack.ngo> ; 
takal@jack.ngo <mailto:takal@jack.ngo> ; mirzaee@jack.ngo 
<mailto:mirzaee@jack.ngo> ; ahf-finance@jack.ngo 
<mailto:ahf-finance@jack.ngo> ; pharmacy@jack.ngo <mailto:pharmacy@jack.ngo>
Subject: Rejected and not received medicine

Dear Dr Sahib Jamal

Greetings from Kunduz office

First of all thank you very much for a very quick procurement of AHF trauma 
medicine, the quality and the quantitiy is good and appreciated.

However, there are difference in 11 items, as we explained and the report 
was shared with the pharmacy/warehouse responsible. I hope it has reached to 
you and I would like to kindly request on the process speed up.

I would be glad to hear from your dear dr Sahib.

Thank you & Best Regards

Dr-Mohammad Hashim “Safar” MD/GP/Social Service Provider

Project Manager-AHF Project / NER PSEA Focal Point / Mental Health Focal 
Point

Just for Afghan Capacity and Knowledge       بلند بردن سطح دانش و توانمندی 
افغانها (جک)

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93792 716 026 – +93777 469 663 – 
+93706 179 758

Official Email: <mailto:Dr.Safar@jack.ngo> Dr.Safar@jack.ngo

Personal Email: <mailto:Dr.Safar001@outlook.com> Dr.Safar001@outlook.com – 
<mailto:Dr.Safar@yahoo.com> Dr.Safar@yahoo.com

Website:www.jack.ngo

------=_NextPart_001_10849_01D807FC.D78C2A70
Content-Type: text/html;
	boundary="----=_NextPart_000_001D_01D7B2CC.1AD92570";
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" =
xmlns=3D"http://www.w3.org/TR/REC-html40"><head><meta =
http-equiv=3DContent-Type content=3D"text/html; charset=3Dutf-8"><meta =
name=3DGenerator content=3D"Microsoft Word 15 (filtered medium)"><style></style></head><body lang=3DEN-US =
link=3D"#0563C1" vlink=3D"#954F72"><div class=3DWordSection1><a name=3D"_MailEndCompose">Dear Takal Sahib<o:p></o:p></a><o:p>&nbsp;</o:p>As per pressure from =
Taliban at the time of implementing Trauma project in field, we had a =
request of medicine change from Main office, it was accepted and the =
cost was 23530 Afghanis. <o:p></o:p>The mission was to =
change 450 Falgyl Syrup to 450 Flagyl Serum and 2250 Salin 500ml to 2250 =
Saline 1000ml.<o:p></o:p>We received the total amount from supplier (450 =
Falgyl Serum and 2250 Salin 1000ml), <o:p></o:p>but we did not deliver =
the total amount we promised.<o:p></o:p>We delivered 295 Falgyl =
Syrup and 2230 Saline 500ml serums. We could not deliver 155 Flagyl =
Syrup and 30 Saline 500ml<o:p></o:p><o:p>&nbsp;</o:p>You can go through my =
previous email for the reasons.<o:p></o:p><o:p>&nbsp;</o:p>According to market =
prices, each Falgyl syrup is cost 33 Afghanis and each Serum Salin 500ml =
is cost 22 Afghanis.<o:p></o:p>155x33=3D 5115<o:p></o:p>30x22=3D =
660<o:p></o:p><o:p>&nbsp;</o:p>In total 5775 Afghanis. =
This amount medicines were available in our FATPs, our Pharmacy =
assistant was not able to receive them, when we asked them after several =
days, he responded that the Taliban forcefully did not deliver the =
medicines. <o:p></o:p><o:p>&nbsp;</o:p>Beside from invoice, we =
have to pay 23530+5775=3D 29305 Afghanis to the supplier. The amount =
5775 should be deducted from Pharmacy assistant=E2=80=99s salary (after =
clarification with him) and 23530 from any other financial line (the =
last quarter lines were not used in Kunduz =
province)<o:p></o:p><o:p>&nbsp;</o:p><div>Thank you &amp; Best =
Regards<o:p></o:p><o:p>&nbsp;</o:p><=
img width=3D239 height=3D85 id=3D"Picture_x0020_2" =
src=3D"cid:image001.jpg@01D7B2CC.17090AA0"><o:p></o:p><=
o:p>&nbsp;</o:p><=
img width=3D236 height=3D99 id=3D"Picture_x0020_3" =
src=3D"cid:image002.jpg@01D7B2CC.17090AA0"><o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Emergency projects Technical =
Manager<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93790807013 =E2=80=93 +93777 469 663<o:p></o:p>Official Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>Personal Email: &nbsp;<a =
href=3D"mailto:Dr.Safar@yahoo.com">Dr.Safar@yahoo.com</a><o:p></o:p>Skype ID: <a =
href=3D"mailto:Dr.Safar001@outlook.com">Dr.Safar001@outlook.com</a>=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=
=A0=C2=A0=C2=A0 <o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
/div><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: dr.safar@jack.ngo =
[mailto:dr.safar@jack.ngo] Sent: Wednesday, August 4, 2021 =
11:01 AM To: 'ahmad@jack.ngo' =
&lt;ahmad@jack.ngo&gt; Cc: 'hadi@jack.ngo' =
&lt;hadi@jack.ngo&gt;; 'logistic.manager@jack.ngo' =
&lt;logistic.manager@jack.ngo&gt;; 'fatima.qasimi@jack.ngo' =
&lt;fatima.qasimi@jack.ngo&gt;; 'finance.manager@jack.ngo' =
&lt;finance.manager@jack.ngo&gt;; 'takal@jack.ngo' =
&lt;takal@jack.ngo&gt;; 'nooromari@jack.ngo' =
&lt;nooromari@jack.ngo&gt; Subject: RE: Rejected and not =
received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr Ahmad<o:p></o:p><o:p>&nbsp;</o:p>As per below emails and =
justifications, 155 Flagyl syrups and 30 Serum saline were not delivered =
to the supplier according to our exchange plan.<o:p></o:p><o:p>&nbsp;</o:p>The exchange plan was =
to: <o:p></o:p><![if =
!supportLists]>=C2=B7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>450 Flagyl Syrup should have been replaced with =
450 Flagyl solution<o:p></o:p><![if =
!supportLists]>=C2=B7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>2250 saline syrum of 500 Mile liter should have =
been replaced to 2250 Saline syrum 1000 Mile =
Liter<o:p></o:p><o:p>&nbsp;</o:p>295 flagyl syrup was =
delivered to the supplier, however, 155 was missed from Pharmacy =
assistant Mr Hakim Mangal as he said AOGs did not give them the =
exchanged Flagyl syrups.<o:p></o:p><o:p>&nbsp;</o:p>From 2250 Syrums, total =
2220 Syrums were delivered to supplier. 30 syrums remained from the =
exchange, the reasons was when the first supply happened to Jan =
Qataghan, the syrums of 1000 Mile Liter was sent, however, the exchange =
of it was not brought back to stock. Later AOGs only gave them 420 =
syrums, 30 was used by FATP staff.<o:p></o:p><o:p>&nbsp;</o:p>Total: 155 Flagyl syrup and 30 Saline 500 Mile liter =
was left and the reason was that Mr Hakim Mangal sent the medicine to =
FATPs and did not bring back it=E2=80=99s exchange, he said AOGs did not =
permit.<o:p></o:p>The real was that Mr Mangal reported the issue =
after 3 days. When the issue was followed up, FATP staff said we have =
submitted and there were no documents for hand over/take over. Not =
having a clear document for takeover of medicine was the fault of =
Pharmacy assistant.<o:p></o:p><o:p>&nbsp;</o:p>Conclusion: =
&nbsp;I would like to kindly =
request from top management team that declare their decision on the =
above mentioned issue. As it was raised by myself even months ago and =
there is no clear decision taken until now.<o:p></o:p><o:p>&nbsp;</o:p>Thanks in =
advance<o:p></o:p><o:p>&nbsp;</o:p><div>Thank you &amp; Best =
Regards<o:p></o:p><img border=3D0 width=3D61 =
height=3D48 id=3D"_x0000_i1025" =
src=3D"cid:image003.jpg@01D7891A.FD9F0090" =
alt=3D"cid:image003.jpg@01D4B669.F250F440"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Emergency projects focal point / COVID-19 =
Vaccination technical focal point<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93790807013 =E2=80=93 +93777 469 663<o:p></o:p>Official Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>Personal Email: &nbsp;<a =
href=3D"mailto:Dr.Safar@yahoo.com">Dr.Safar@yahoo.com</a><o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
/div><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Monday, June 21, 2021 8:30 AM To: <a =
href=3D"mailto:fatima.qasimi@jack.ngo">fatima.qasimi@jack.ngo</a> C=
c: <a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>; <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a> Subject: FW: =
Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Tuesday, May 4, 2021 1:28 PM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt;; =
'nooromari@jack.ngo' &lt;<a =
href=3D"mailto:nooromari@jack.ngo">nooromari@jack.ngo</a>&gt; Subje=
ct: RE: Rejected and not received =
medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Sahib Safar,<o:p></o:p><o:p>&nbsp;</o:p>Thanks from your email =
and justifications, the attached informal GRN shows that the medicines =
delivered to supplier without pharmacy committee and incomplete, but =
KDZ-AHF team promised to deliver complete rejected amount to supplier, =
the financial cost of this exchange was and will =
be:<o:p></o:p><![if =
!supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Complete exchange cost: 23,530 AFN =
<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Incomplete exchange cost: 41,590 =
AFN<o:p></o:p>As now the medicine delivered to supplier =
incompletely, I would like to know how we should pay 41,590 AFN to =
supplier, looking forward to hear from you soon.<o:p></o:p><o:p>&nbsp;</o:p>Dear En. Sahib =
Hadi,<o:p></o:p><o:p>&nbsp;</o:p>Kindly refer to below =
emails and let us know your comments.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a> [<a =
href=3D"mailto:dr.safar@jack.ngo">mailto:dr.safar@jack.ngo</a>] =
 Sent: Monday, May 3, 2021 9:49 PM To: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a>; <a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a> Cc: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>; <a =
href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>; <a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>; <a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>; <a =
href=3D"mailto:nooromari@jack.ngo">nooromari@jack.ngo</a> Subject:<=
/b> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr Jamal<o:p></o:p><o:p>&nbsp;</o:p>As per investigations, I =
found out there are two problems.<o:p></o:p><![if !supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Only 295 flagyl syrups were submitted to =
Supplier, in this case, Haji Naim Jan clininc flagyl syrup were not =
received although Pharmacy assistant delivered Metrogyls, however he =
says the AOG responsible did not give me flagyl =
syrups<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>When we delivered the sample medicine to Jan =
Qataghan of Khanabad district for AOG check up, the Salin 500 Ml syrums =
were sent as well, however after rejection, they were not collected =
back, due to AOG said rejected medicine should be replaced in FATP. When =
we wanted to deliver the 1000 Ml syrums of Salin, the pharmacy assistant =
did not collected salin 500 ml back. Then the ban started from march 12 =
=E2=80=93 2021 1st May 2021. Now when he called to the AOGs =
that we want our 450 Salin 500 mL syrums back, then AOG responsible =
replied that =E2=80=9Cnot collecting back the serums were NGOs fault and =
now we will not give it back we have sealed those serums and we will use =
it for our purpose=E2=80=9D.<o:p></o:p><o:p>&nbsp;</o:p>The conclusion: Two =
times the medicine were sent, however they were not collected back by =
Pharmacy assistant. <o:p></o:p><o:p>&nbsp;</o:p>The rest of the decision =
is up to Kabul Management team what they decide, the cleareance of each =
and every staff is up hold, the decision on this section is easy if the =
AOGs do not give us back serums and flagyl =
syrups.<o:p></o:p><o:p>&nbsp;</o:p>Currently I am =
communicating through community access mobilizer, will share the result =
of what is the final words of AOGs by tomorrow =
CoB.<o:p></o:p><o:p>&nbsp;</o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Project Manager-AHF =
Project<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93792711163<o:p></o:p>Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>Email: <a =
href=3D"mailto:Parvez.Safar@gmail.com">Parvez.Safar@gmail.com</a> <o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
div><div style=3D'border:none;border-top:solid #E1E1E1 =
1.0pt;padding:3.0pt 0in 0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Monday, May 3, 2021 1:18 PM To: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>; <a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a> Cc: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>; <a =
href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>; <a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>; <a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>; <a =
href=3D"mailto:nooromari@jack.ngo">nooromari@jack.ngo</a> Subject:<=
/b> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Gentle Reminder!<o:p></o:p><o:p>&nbsp;</o:p>Dear AHF Team need your =
response regarding the subject issue, also let us know the way you =
delivered medicine to supplier along with delivered amount, looking =
forward to hear from you soon.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Saturday, May 1, 2021 1:53 PM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt; Subject:</b=
> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Safar and Amrullah =
Khan,<o:p></o:p><o:p>&nbsp;</o:p>I hope you have been =
well, based on your request and top management approval we have =
exchanged the rejected medicine to requested medicine which your all =
fully aware of that, now we have pay 23,530 AFN to supplier due to =
exchange rate, to let you know finance team will pay the main =
procurement cost to supplier only exchange cost rate will be paid by you =
as it was agreed, attached is the supplier bank details, if there be any =
question please contact to finance team.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Tuesday, March 30, 2021 10:26 AM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt; Subject:</b=
> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Safar,<o:p></o:p><o:p>&nbsp;</o:p>I am glad that you =
received the requested medicine for 4th Qtr of AHF project, =
which I didn=E2=80=99t get your confirmation nor GRN, please let me know =
about following comments:<o:p></o:p><![if !supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Vicryl 4/1 is not available at the market, which =
size will be the alternative (Vicryl size 4 or Vicryl size =
1).<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Per your request and senior management approval =
we discussed and agreed with supplier to exchange the two rejected items =
(Serum-Saline 500ml &amp; Syrup-Metro 200mg/30ml) to requested items =
(Serum-Saline 1000ml &amp; Serum-Metro 500mg/30ml) beyond the main =
contract, now supplier is confused that when I will receive the =
exchanged items because he already send his representative three times =
to PO-M.Stock, in order to receive the exchange medicine but due to none =
reason the process get postponed, I would like to know if there is any =
problem and the exact time when your able to deliver the exchanged items =
to supplier.<o:p></o:p>Please let me know if there is anything that I =
can help you to accelerate the process and close the procurement =
process.<o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p>Best =
Regards,<o:p></o:p><o:p>&nbsp;</o:p><img border=3D0 =
width=3D49 height=3D38 id=3D"Picture_x0020_1" =
src=3D"cid:image006.jpg@01D7891A.FD9F0090" =
alt=3D"cid:image003.jpg@01D4B669.F250F440"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>JAMAL&nbsp;&nbsp; Pharm.D<o:p></o:p>Procurement / Pharmacy =
Manger<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: 1st Street of Karta-e-Chahar, =
Kabul Afghanistan <o:p></o:p>Behind AWCC Main Office, House # =
09<o:p></o:p>What=E2=80=99s app: +93 744 402 =
619<o:p></o:p>Email: <a =
href=3D"mailto:pharm.dmrjamal@gmail.com">pharm.dmrjamal@gmail.com</a></sp=
an>&nbsp; <o:p></o:p>Website:www.jack.ngo <o:p></o:p>=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
<o:p></o:p>This e-mail and any files =
transmitted with it may contain privileged or confidential information. =
It is solely for use by the individual for whom it is intended, even if =
addressed incorrectly. If you received this e-mail in error, please =
notify the sender; do not disclose copy, distribute, or take any action =
in reliance on the contents of this information; and delete it from your =
system. Any other use of this e-mail is prohibited. The views expressed =
herein are those of the author and do not necessarily reflect the views =
or policies of jack (Afghanistan). Electronic transmissions may be =
recorded and monitored.For Verification Please Read =
the Barcode Reader.&nbsp; <o:p></o:p><![if !vml]><table cellpadding=3D0 cellspacing=3D0 =
align=3Dleft><tr><td width=3D2 =
height=3D1198></td></tr><tr><td></td><td><img width=3D115 height=3D115 =
src=3D"cid:image005.jpg@01D7B2CC.17090AA0" alt=3D"jack smart code" =
v:shapes=3D"Picture_x0020_1"></td></tr></table><![endif]><o:p>&nbsp;</o:p></=
p><o:p>&nbsp;</o:p><o:p>&nbsp;</=
o:p><o:p>&nbsp;</=
o:p> P<s=
pan =
style=3D'font-size:7.5pt;font-family:"Arial",sans-serif;color:green'> =
Ever=
y 3000 sheets of paper costs us a tree. Please don't print this e-mail =
unless you really need to<o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Tuesday, March 16, 2021 10:13 AM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt; Subject:</b=
> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Sahib Safar,<o:p></o:p><o:p>&nbsp;</o:p>Thanks from your email, =
please review below comments:<o:p></o:p><![if !supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>I received the draft of GRN and I found =
difference at 11 items, as I shared the list with supplier he send his =
representative to PO to solve the supply issue immediately, again I will =
follow this issue with supplier and will communicate you via =
phone.<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>As we have agreed with supplier to exchange the =
two items which are quarantine right now at P-Stock and you received the =
replacement, please make them ready and pack in exact Qty and good =
package, please do the exchange process in presence of pharmacy =
committee.<o:p></o:p><![if =
!supportLists]>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>As I already talked with pharmacy team, so =
please inform them to prepare the GRN with all required info such as =
(expiry date, batch number, company &amp; country, Qty, =
etc..).<o:p></o:p><![if =
!supportLists]>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>As you all aware that AHF-Projects will be audit =
by 3rd party team, so please inform the AHF pharmacy in =
charge to fully get ready for assessment.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a> [<a =
href=3D"mailto:dr.safar@jack.ngo">mailto:dr.safar@jack.ngo</a>] =
 Sent: Monday, March 15, 2021 6:50 PM To: <a =
href=3D"mailto:logitic.manager@jack.ngo">logitic.manager@jack.ngo</a> =
Cc: <a href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>; <a =
href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>; <a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>; <a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> Subject:</b=
> Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr =
Sahib Jamal<o:p></o:p>Greetings from Kunduz =
office<o:p></o:p><o:p>&nbsp;</o:p>First of all thank you very much for a very quick =
procurement of AHF trauma medicine, the quality and the quantitiy is =
good and appreciated.<o:p></o:p><o:p>&nbsp;</o:p>However, =
there are difference in 11 items, as we explained and the report was =
shared with the pharmacy/warehouse responsible. I hope it has reached to =
you and I would like to kindly request on the process speed up. =
<o:p></o:p><o:p>&nbsp;</o:p>I would be glad to hear from your dear dr =
Sahib.<o:p></o:p><o:p>&nbsp;</o:p>Thank you &amp; Best =
Regards<o:p></o:p><img border=3D0 width=3D49 =
height=3D38 id=3D"_x0000_i1027" =
src=3D"cid:image009.jpg@01D7891A.FD9F0090"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Project Manager-AHF Project / NER PSEA =
Focal Point / Mental Health Focal Point<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93792 716 026 =E2=80=93 +93777 469 663 =E2=80=93 +93706 179 =
758<o:p></o:p>Official Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>Personal Email: <a =
href=3D"mailto:Dr.Safar001@outlook.com">Dr.Safar001@outlook.com</a> =
=E2=80=93 <a href=3D"mailto:Dr.Safar@yahoo.com">Dr.Safar@yahoo.com</a><o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
p class=3DMsoNormal><o:p>&nbsp;</o:p></div></body></html>
------=_NextPart_001_10849_01D807FC.D78C2A70--

------=_NextPart_000_10848_01D807FC.D78C2A70
Content-Type: image/jpeg;
	name="image003.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image003.jpg@01D7891A.FD9F0090>

------=_NextPart_000_10848_01D807FC.D78C2A70
Content-Type: image/jpeg;
	name="image006.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image006.jpg@01D7891A.FD9F0090>
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------=_NextPart_000_10848_01D807FC.D78C2A70
Content-Type: image/png;
	name="image007.png"
Content-Transfer-Encoding: base64
Content-ID: <image007.png@01D7891A.FD9F0090>

iVBORw0KGgoAAAANSUhEUgAAASIAAAEiAQAAAAB1xeIbAAAABGdBTUEAALGOfPtRkwAAAAlwSFlz
AAAOxAAADsQBlSsOGwAAABl0RVh0U29mdHdhcmUATWljcm9zb2Z0IE9mZmljZX/tNXEAAAEMSURB
VGje7dnBDYMwDIVhSwzASKzOSAxQySWOE1pooIcYqdWfA1LCd3uynVLRL9YsKBQKhfoLJb4GlWkZ
1oOlnEyoaGUbXVw5rS9QoSpFYu/mEpMHhrpNvWSFulvlfoS6UZVc8kC46l+ojup9IufAruY2qova
LQ/s4r6K6qNsDkt52Fbn8bFLCBWgRNJJBqOdPOSYECpEpVaUwZZVHQ2oSOWVYMNYS02oHmoIFaB8
LJemlO9FtURQgcpyWTciZxMZFaGsKW0TuXUTRYUqr4mPv8BQkcqnQuOrDypClcKonQl1n7I7kKl0
L2p+7UT1V7kf5RIZtfUPCypEWS5bOM2JjOqvzhcKhUKhfl49AcZAJK+rvDc4AAAAAElFTkSuQmCC

------=_NextPart_000_10848_01D807FC.D78C2A70
Content-Type: image/jpeg;
	name="image009.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image009.jpg@01D7891A.FD9F0090>
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------=_NextPart_000_10848_01D807FC.D78C2A70
Content-Type: image/jpeg;
	name="image001.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image001.jpg@01D7B2CC.17090AA0>
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------=_NextPart_000_10848_01D807FC.D78C2A70
Content-Type: image/jpeg;
	name="image002.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image002.jpg@01D7B2CC.17090AA0>
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------=_NextPart_000_10848_01D807FC.D78C2A70
Content-Type: image/jpeg;
	name="image005.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image005.jpg@01D7B2CC.17090AA0>
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------=_NextPart_000_10848_01D807FC.D78C2A70--